Rubino, Domenica, et al
For example, if you inject weekly, you might use your abdomen one week, your right thigh the next, your left thigh the following week, and your arm (with assistance) the fourth week, then return to the abdomen in a different location
The 48 week BELIEVE Phase 2 compared a multiple placebo arm to semaglutide4 (1.0mg or 2.4mg), bimagrumab (10 mg/kg, 30 mg/kg), and sema-bima (1.0mg, 2.4mg semaglutide X 10 mg/kg, 30 mg/kg bimagrumab)
Off-label use in younger patients occurs in clinical practice, but such decisions require careful provider assessment of risk-benefit, family history, and metabolic status
Commercial patches are cheaper because they dont contain the actual GLP-1 medication found in prescription injections
This publication has not independently audited current licensing, operations, fulfillment, or dispensing practices